For comments, suggestions
Created with Raphaël 2.1.0 20.12.2012 Opening of the national phase 10.01.2013 Preliminary and substantive examination 31.05.2013 Publication of the PCT application (A2) 31.08.2015 Publication of the decision of grant (B1) 29.02.2016 Completion of the opposition filing period 31.03.2016 Issuance of patent (C1) 25.08.2024 19.05.2025 Valid until 19.05.2026 Payment of maintenance fee 19.05.2031 Patent expiration date

Patent in force


(11)Number of the document4363
(21)Number of the applicationa 2012 0125
(22)Filing date of the application2011.05.19
 Date of filing the request for examination (de fond) 02.06.2015
(71)Name(s) of applicant(s), code of the countryE.I. DU PONT DE NEMOURS AND COMPANY, US;
(72)Name(s) of inventor(s), code of the countryCURRIE Martin James, US;
(73)Name(s) of owner(s), code of the countryE.I. DU PONT DE NEMOURS AND COMPANY, US;
(54)Title of the inventionCrystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide and uses thereof
(13)Kind-of-document code
C1, BOPI 03/2016
B1, BOPI 08/2015
A2, BOPI 05/2013
(51)International Patent Classification C07D 261/04 (2006.01); A01N 43/80 (2006.01); A01P 5/00 (2006.01); A01P 7/00 (2006.01); A61K 31/42 (2006.01); A61P 33/00 (2006.01);
(19)CountryUS
(41)Date of publication of the application2013.05.31
(45)Date of publication of patent granting decision:2015.08.31
(47)Date of issuance of patent2016.03.31
(30)Priority61/348,958, 2010.05.27, US
(74)Patent attorneySOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chiєinгu, Republica Moldova
 Substantive examiner(s)JOVMIR Tudor
(85)Date of introducing the national procedure2012.12.20
(86)International applicationPCT/US2011/037083, 2011.05.19
(87)International publicationWO 2011/149749 A1, 2011.12.01
 Payment for maintenance up to the date2025.05.19
Up
/inventions/Details.aspx?id=a+2012+0125